Antibodies US 2023 Post-event Report
San Diego, CA13 - 16 December 2023
Welcome to the post-event wrap-up of the 34th annual Antibody Engineering & Therapeutics US 2023 conference, recognized for being the leading knowledge and networking hub in the antibody industry. From December 13 – 16, 2023, more than 900...
Introduction
Tackling Tough Targets in Antibody Discovery by Leveraging a Diverse Suite of In Vivo Discovery Platforms
Accelerating Early Discovery Through HTP and High-Speed Antibody Production
Democratizing Access to Broad B Cell Diversity for Rapid Monoclonal Antibody Discovery from Humans and Beyond
Accelerating Chimeric Antigen Receptor Discovery: From Targets to Leads with ProCAR™ Platform
Human Antibody Responses to Infection and Vaccination
Enhance and Expand Anti-ID Antibody Diversity and Affinity Through Genetic Immunization
ALTHEA Libraries: Phage Display Libraries for Antibody Therapeutic Discovery and Development
Transgenic Chickens Producing Human Heavy Chain-only Antibodies Demonstrate Robust Immune Repertoires and High-affinity Binding
Xencor’s 20 Year Journey in Antibody Therapeutic Development
Efficient Therapeutic Development Using The Pfenex Expression Technology® Platform
Software at Every Stage: Achieving Antibody Discovery at Scale
How to Use Display Technologies to Discover Therapeutic Proteins Against Challenging Targets
Evolution of Stromal Niches in Inflammation, Cancer and Immunotherapy
Exhibitor Spotlight